Dr. Lyndsay Willmott
The easiest way to think of how PARP inhibitors work in cancer cells is that they're "taking away the crutches from someone who has a broken leg," says Dr. Willmott. "But for a cancer cell that's a good thing because we want the cancer cell to die."